The study demonstrated the success of an optofluidic-based Point-of-Care (PoC) diagnostic system for the analysis of protein-protein interactions. Today SCIENION, a BICO company and leading […]

Supplier Code of Conduct Internal Code of Conduct Whistleblower/speak-up Channel

Get the latest from SCIENION Sign up to our mailing list to stay updated on the latest SCIENION news, product launches and events. Name * […]

The breakthrough diagnostics platform uses a multiplexed lateral flow assay that detects 10 bladder cancer biomarkers from a urine sample in either laboratory or point-of-care […]

Available today, the proteoCHIP 12*16 facilitates automated, miniaturized solutions for single cell proteomics applications Today, SCIENION & Cellenion, BICO companies, announced the release of the […]

The partnership will incorporate SCIENION’s CL2 sciREADER system into the PictArray SARS-CoV-2 Serology Test which will shortly begin clinical trials for FDA EUA market clearance […]

Since its foundation in 2001, SCIENION GmbH has been located in the Adlershof Science & Technology Park in Berlin, Germany. The life sciences company is […]

Potsdam and Berlin, Germany; March, 18, 2021: GILUPI GmbH and SCIENION AG today announced that the companies intend to intensify their collaboration in the field […]